A significant breakthrough in cancer research is emerging with the use of VHH fragments to reactivate mutated p53. This vital cancer inhibitor protein is frequently inactivated in several forms of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research